市場調査レポート
商品コード
1071709
ラジオイムノアッセイの世界市場規模:用途、タイプ、地域別の予測(2022年~2028年)Global Radioimmunoassay Market Size study, by Application (Research, Clinical Diagnostics), by Type (Reagents & Kits, Analyzer) and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ラジオイムノアッセイの世界市場規模:用途、タイプ、地域別の予測(2022年~2028年) |
出版日: 2022年04月22日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界のラジオイムノアッセイの市場規模は、2021年に約4億4,980万米ドルとなり、2022年~2028年の間の予測期間中に5.00%以上の好調な成長率で成長すると予測されています。
製薬業界におけるRIA(ラジオイムノアッセイ)の使用量の増加、深刻な公害を伴う都市化により、予測期間中にラジオイムノアッセイの採用が進んでいます。また、腫瘍検査の増加に伴い、ラジオイムノアッセイの採用と需要が、予測期間中の市場成長を増大させると期待されます。しかし、厳しい規制当局の承認が、2022年~2028年の間の予測期間中の市場成長を妨げています。
当レポートでは、世界のラジオイムノアッセイ市場について調査分析し、市場動向、競合情勢、セグメント別・地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。
List of figures
Global Radioimmunoassay Market is valued at approximately USD 449.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.00 % over the forecast period 2022-2028. Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in the blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody-antigen binding and their quantitation by using radioactivity. The method is hypersensitive and can quantify tiny amounts of hormone or drug levels with the help of antibodies. The increasing usage of RIA in pharmaceutical industries, urbanization with heavy pollution has led to the adoption of Radioimmunoassay across the forecast period. For Instance: As per the United Nations' Department of Economic and Social Affairs Population Dynamics, by 2050 it's projected that more than two-thirds of the world's population will live in urban areas. It's projected that close to 7 billion people will live in urban areas in 2050. Also, with the increasing oncology testing, the adoption & demand for Radioimmunoassay is likely to increase the market growth during the forecast period. However, stringent regulatory approvals impede the growth of the market over the forecast period of 2022-2028.
Global Radioimmunoassay Market is segmented on the basis of geographical reasons as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is deemed as the leader of the market and witnessed robust growth owing to growing technological advancements in clinical therapy, growing oncology testing. Whereas, Asia-Pacific is coming up as one of the promising regions as huge market growth is observed due to factors such as rising population, growing health awareness would create profitable growth prospects for the Radioimmunoassay Market across Asia-Pacific region.
Major market players included in this report are:
MP Biomedicals LLC
DiaSorin S.P.A.
Euro Diagnostica AB
Merck Millipore Corporation
DIAsource ImmunoAssays S.A
Stratec Biomedical AG
Berthold Technologies Gmbh & Co. Kg
iZotope
Beckman Coulter, Inc.
Cisbio
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Research
Clinical Diagnostics
By Type:
Reagents & Kits
Analyzer
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Radioimmunoassay Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors